Drug intelligence / Profile preview

Iodohippuric acid

Development stage
Unknown
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
Administration
Intravenous
01

Overview

Iodohippuric acid is a small molecule radiopharmaceutical primarily used as a renal imaging agent to assess effective renal plasma flow and kidney function. It is an analog of p-aminohippuric acid, labeled with radioactive iodine isotopes (such as I‑125 or I‑131), and is administered intravenously for renography. The compound is rapidly cleared from the bloodstream by tubular secretion in the kidneys, making it highly suitable for dynamic kidney imaging. In patients with normal renal function, approximately 85% of administered iodohippuric acid can be recovered in urine within 30 minutes after injection. Its mechanism of action relies on its filtration and active secretion by the renal tubules, allowing quantitative assessment of renal plasma flow and tubular function[1][3][7]. Historically, it has been considered a standard for measuring effective renal plasma flow but has largely been replaced by newer agents due to concerns about radiation exposure from certain isotopes[7][8].

Brand names
HippuranRadio HippuranRadio-HippuranRadioHippuran
Other names
ortho-Iodohippuric acidortho-IodohippurateSodium iodohippurateSodium o-iodohippurateOrthoiodohippurateIodobenzoylglycine2-Iodohippuric acid2-(2-Iodobenzamido)acetic acidN-(2-Iodobenzoyl)glycine
02

Targets

OAT1 (Organic anion transporter 1)OAT2 (Solute carrier family 22 member 7)SLC22A8 (Organic anion transporter 3)

Beyond the preview

Go deeper on Iodohippuric acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iodohippuric acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call